Q32 Bio
Latest round
- Series B
Last raised
- Oct 2020
Total raised
- $106M
Investors
- 8
About Q32 Bio
Q32 Bio Inc. is a biotechnology company specializing in the development of innovative immune therapeutics targeting autoimmune and inflammatory diseases.Founded in 2020 and headquartered in Cambridge, US, Q32 Bio Inc. is dedicated to creating advanced therapies for autoimmune conditions.00 mn.Q32 Bio focuses on developing targeted immune therapeutics aimed at addressing autoimmune and inflammatory diseases. Their primary product candidate, Bempikibart (ADX-914), is a fully human anti–interleukin-7 receptor alpha (IL-7Ra) antagonist monoclonal antibody designed to re-regulate adaptive immune function. By blocking IL-7 and thymic stromal lymphopoietin (TSLP) signaling, Bempikibart seeks to transform the treatment landscape for conditions such as alopecia areata (AA).156 mn. The revenue generation strategy revolves around the development and potential commercialization of Bempikibart. The company engages in partnerships with healthcare providers and institutions for clinical trials and research, which serve as key avenues for transaction activities.Q32 Bio plans to utilize its recent MERGER on November 16, 2023, with Homology Medicines, Inc. to expand its operations under the Q32 Bio Inc. name, with an expected listing on the Nasdaq Global Market under the ticker "QTTB". The company is looking to accelerate the clinical development of Bempikibart and expand its market reach into new geographic regions, specifically targeting North America and Europe by 2024.
Who invested in Q32 Bio
8 investors across 2 rounds
See all investors in Q32 Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Q32 Bio
Who invested in Q32 Bio?
Q32 Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Q32 Bio raised?
Q32 Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Q32 Bio last raise money?
Q32 Bio's most recent round on record is a Series B, in Oct 2020.
What does Q32 Bio do?
Q32 Bio is a biotechnology company.
Where is Q32 Bio headquartered?
Q32 Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Q32 Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Q32 Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Q32 Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.